NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas
Authors:
- Shama ViraniSVShama Virani
- Emily BellileEBEmily Bellile
- Carol R. BradfordCBCarol R. Bradford
- Thomas E. CareyTCThomas E. Carey
- Douglas B. ChepehaDCDouglas B. Chepeha
- Justin A. ColacinoJustin A. Colacino
- Joseph I. HelmanJHJoseph I. Helman
- Jonathan B. McHughJMJonathan B. McHugh
- Lisa A. PetersonLPLisa A. Peterson
- Maureen A. SartorMSMaureen A. Sartor
- Jeremy Mg TaylorJTJeremy Mg Taylor
- Heather M. WallineHWHeather M. Walline
Open Access
- 30 October 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 825
Abstract
HPV-associated HNSCCs have a distinct etiologic mechanism and better prognosis than those with non-HPV associated HNSCCs. However, even within the each group, there is heterogeneity in survival time. Here, we test the hypothesis that specific candidate gene methylation markers (CCNA1, NDN, CD1A, DCC, p16, GADD45A) are associated with tumor recurrence and survival, in a well-characterized, prospective, cohort of 346 HNSCC patients. Kaplan-Meier curves were used to estimate survival time distributions. Multivariable Cox Proportional Hazards models were used to test associations between each methylation marker and OST/RPFT after adjusting for known or identified prognostic factors. Stratified Cox models included an interaction term between HPV and methylation marker to test for differences in the associations of the biomarker with OST or RPFT across HPV status. Methylation markers were differentially associated with patient characteristics. DNA hypermethylation of NDN and CD1A was found to be significantly associated with overall survival time (OST) in all HNSCC patients (NDN hazard ratio (HR): 2.35, 95 % CI: 1.40-3.94; CD1A HR: 1.31, 95 % CI: 1.01-1.71). Stratification by HPV status revealed hypermethylation of CD1A was associated with better OST and recurrence/persistence-free time (RPFT) (OST HR: 3.34, 95 % CI: 1.88-5.93; RPFT HR: 2.06, 95 % CI: 1.21-3.49), while hypomethylation of CCNA1 was associated with increased RPFT in HPV (+) patients only (HR: 0.31, 95 % CI: 0.13-0.74). This study is the first to describe novel epigenetic alterations associated with survival in an unselected, prospectively collected, consecutive cohort of patients with HNSCC. DNA hypermethylation of NDN and CD1A was found to be significantly associated with increased overall survival time in all HNSCC patients. However, stratification by the important prognostic factor of HPV status revealed the immune marker, CD1A, and the cell cycle regulator, CCNA1 to be associated with prognosis in HPV (+) patients, specifically. Here, we identified novel methylation markers and specific, epigenetic molecular differences associated with HPV status, which warrant further investigation.Keywords
This publication has 57 references indexed in Scilit:
- Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancerBritish Journal of Cancer, 2013
- Human Papillomavirus–Positive Oral Cavity and Oropharyngeal Cancer Patients Do Not Have Better Quality‐of‐Life TrajectoriesOtolaryngology–Head and Neck Surgery, 2012
- Complex Etiology Underlies Risk and Survival in Head and Neck Cancer Human Papillomavirus, Tobacco, and Alcohol: A Case for Multifactor DiseaseJournal of Oncology, 2012
- Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancerThe Laryngoscope, 2011
- Role of DNA methylation in head and neck cancerClinical Epigenetics, 2011
- Higher Micronutrient Intake Is Associated With Human Papillomavirus-Positive Head and Neck Cancer: A Case-Only AnalysisNutrition and Cancer, 2011
- Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2010
- HPV‐positive/p16‐positive/EBV‐negative nasopharyngeal carcinoma in white North AmericansHead & Neck, 2010
- Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor RecurrenceClinical Cancer Research, 2010
- Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomasEuropean Journal of Cancer, 2007